Clinical Trials · NCT02456428
Incretin-based Drugs and the Risk of Heart Failure
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Canadian Network for Observational Drug Effect Studies, CNODES
- Enrollment
- 1,499,650
- Start date
- Mar 2014
- Locations
- 1 site, Canada
- Primary endpoint
- Hospitalization for incident heart failure